Navigation Links
Direct Image High-Mag SSV®

ProductsDirect Image High-Mag SSV®
Company Volk Optical, Inc.
Item Direct Image High-Mag SSV®
Features 
  • Provides high magnification, high resolution direct image of the central retina
  • Patent pending autoclaveable steam sterilizable materials/design
  • Patented SSV® contact eliminates the need for sutures or rings
Description The High-Mag 1.5x is specifically designed for internal limiting membrane peeling in macular hole surgery, optic nerve neurotomy, sheathotomy and macularepiretinal membrane removal, traditional macular edema and other situations warranting higher magnification. This lens was developed with K.V. Chalam, MD.
Info Volk Optical, Inc.
Customer Service: (800) 345-8655
Web site: http://www.volk.com

Related medicine products :

1. Specialist Direct Ophthalmoscope
2. Vista 20 Direct Ophthalmoscope
3. Pocket Direct Ophthalmoscope
4. Quickert Grooved Director
5. Directional `E and `C Test
6. Bilirubin, Direct & Total
7. Bilirubin Direct Reagent
8. Direct Bilirubin Reagent
9. Direct Focusing Headlight Complete
10. Direct LDL Cholesterol Reagent
11. HDL-Cholesterol Direct Reagent
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products:
(Date:3/30/2015)... March 30, 2015 Tel-Aviv – March ... prescription eyewear, announced the closing of $12.5 million in ... of the Viola Group. The funding will further GlassesUSA's ... leading player in the growing global market of online ... in 2009 by CEO Daniel Rothman, COO Eldad Rothman, ...
(Date:3/30/2015)... Dr. Shahdad Arami is now offering ... $200 off their Invisalign treatment. Many people crave straighter ... mouthful of metal. Invisalign offers an alternative. According to ... effective for straightening teeth but has no aesthetic value ... appearance. The Invisalign system allows both teenagers and adults ...
(Date:3/30/2015)... Valerie Harper, the actress best known as ... Mary Tyler Moore Show,” will be the keynote speaker ... magazine announced today. Harper, who is living with terminal ... 40th Annual Congress on April 23 in Orlando, Fla. ... play in the lives of people with cancer. Nominated ...
(Date:3/30/2015)... GenSight ®, provider of an ... leader in The Forrester Wave™: Strategic Planning For The ... independent report positions GenSight as a leader and gave ... 5) for the analytics, corporate strategy, assessment, direction and ... position in the Leaders category. , According to the ...
(Date:3/30/2015)... In an email sent to ECOBOND® LBP, ... TN Community Development Department, announced: “I specifically named Ecobond ... work”. , ECOBOND® LBP, patented lead ... and surpasses other lead paint products because it is ... treats lead dust and lead in paint. While lead ...
Breaking Medicine News(10 mins):Health News:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2Health News:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3Health News:Northridge Cosmetic Dentist, Dr. Arami, is Now Offering a New Promotion on Invisalign 2Health News:Spunky Sitcom Star and Lung Cancer Survivor Valerie Harper to Keynote Extraordinary Healer™ Award Ceremony Honoring Oncoloy Nurses 2Health News:Spunky Sitcom Star and Lung Cancer Survivor Valerie Harper to Keynote Extraordinary Healer™ Award Ceremony Honoring Oncoloy Nurses 3Health News:GenSight Named as a Leader by Independent Research Firm in the Strategic Planning Market 2Health News:GenSight Named as a Leader by Independent Research Firm in the Strategic Planning Market 3Health News:ECOBOND® Selected to Protect School Children in Oak Ridge Tennessee in Lead Based Paint Remediation Project. 2
... , VIRGINIA BEACH, Va., Sept. 10 ... implant of a CardioGraft(TM) allograft cardiac patch product with MatrACELL(TM)( ... in Kansas City, Mo by Gary K. Lofland, ... Mercy Hospital in Kansas City, Mo, The Joseph Boon Gregg/Missouri ...
... LEXINGTON, Ky., Sept. 10 VirtualHealth Technologies, Inc. (OTC Bulletin ... records and connectivity for web-based healthcare solutions, announced today an ... Secure Document Courier and Storage technology (Cifra(TM)) to the healthcare ... will have preferred rights to market Cifra directly to end ...
... , , WASHINGTON, Sept. 10 ... and other leading medical experts today urged Americans to be vigilant ... threat to Americans, health each and every year. , , ... and Americans should begin to get vaccinated now. Seasonal vaccine supply ...
... Researchers at UC Santa Barbara have developed a new way ... to a non-harmful laser. Their results are published in a ... the American Chemical Society. "This entirely novel tool will ... with temporal and spatial control over when a gene is ...
... person,s social life could have an even greater impact than ... growing evidence that being a member of a social group ... and even the common cold. New research by ... of social groups has a positive impact on health and ...
... LOS ANGELES, Sept. 10 Award-winning actresses Edie Falco and ... public service campaign to educate cancer patients and their loved ones ... importance of learning how to manage one,s risk. , , ... http://www.prnewswire.com/mnr/amgen/39907/ , , (Photo: ...
Cached Medicine News:Health News:LifeNet Health and Children's Mercy Hospital Announce First Implant With MatrACELL(TM) Technology 2Health News:LifeNet Health and Children's Mercy Hospital Announce First Implant With MatrACELL(TM) Technology 3Health News:VirtualHealth Technologies Announces Secure eHealth Agreement With DRM Security to Market Secure Document Courier and Storage Platform 2Health News:VirtualHealth Technologies Announces Secure eHealth Agreement With DRM Security to Market Secure Document Courier and Storage Platform 3Health News:VirtualHealth Technologies Announces Secure eHealth Agreement With DRM Security to Market Secure Document Courier and Storage Platform 4Health News:VirtualHealth Technologies Announces Secure eHealth Agreement With DRM Security to Market Secure Document Courier and Storage Platform 5Health News:Americans Urged To Get Seasonal Influenza Vaccine Early 2Health News:Americans Urged To Get Seasonal Influenza Vaccine Early 3Health News:Americans Urged To Get Seasonal Influenza Vaccine Early 4Health News:Americans Urged To Get Seasonal Influenza Vaccine Early 5Health News:Americans Urged To Get Seasonal Influenza Vaccine Early 6Health News:UCSB researchers develop drug delivery system using nanoparticles and lasers 2Health News:Groups are key to good health 2Health News:Groups are key to good health 3Health News:Video: Edie Falco and Cynthia Nixon Appear in New Stand Up To Cancer(TM) PSAs Designed to Educate Cancer Patients About the Importance Of Lowering One's Risk of Infection During Treatment 2Health News:Video: Edie Falco and Cynthia Nixon Appear in New Stand Up To Cancer(TM) PSAs Designed to Educate Cancer Patients About the Importance Of Lowering One's Risk of Infection During Treatment 3
(Date:3/29/2015)... TITUSVILLE, N.J. , March 29, 2015 /PRNewswire/ ... delayed time to relapse compared to placebo in ... 3 clinical study published this week in the ... (JAMA) Psychiatry . Results of ... recent New Drug Application (NDA) filing for three-month ...
(Date:3/27/2015)... March 27, 2015 Across the global healthcare ... challenges in clinical development, market education, and regulatory compliance. ... Medical Affairs function is expected to increase in prominence ... According to research by benchmarking firm, Best ... group dedicated to Medical Affairs. Among companies in ...
(Date:3/27/2015)... , March 27, 2015 /CNW/ - Covalon Technologies Ltd. ... technologies company, today announced the issuance of an aggregate ... the Company and an aggregate of 120,500 stock options ... options will vest over three years and will be ... exercise price of $1.40 per stock option. ...
Breaking Medicine Technology:New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 2New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 3New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 4New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 5New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 6New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 7New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 8New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 9New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 10New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 11New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 12Medical Affairs Capabilities Expanding in Emerging Marketplaces 2Covalon Announces Issuance of Stock Options 2